If you track Linked In, several times a month the consultancy Decibio posts a few key graphics from its industry research.
Let DecibBio catch you up on all that with a free webinar on September 16, 2025 (9 pt, 12 et).
Find it here.
From the website:
Next-generation sequencing (NGS) is transforming oncology care, but adoption varies across specialties, institutions, and testing contexts. Join DeciBio for a data-driven discussion on the current state of NGS in oncology and where adoption is headed next.
The session will open with two brief presentations from our team:
• DxBooks dataset overview: the latest insights on diagnostic test utilization trends.
• Genomics tracker findings: fresh perspectives on adoption dynamics across oncology practice.
We’ll then transition into a stakeholder panel discussion, bringing together oncologists, pathologists, and industry leaders to share real-world perspectives on drivers and barriers to NGS adoption, evolving clinical use cases, and the future of genomic testing in cancer care.
